Low molecular weight heparin or semuloparin should not be recommended for thromboprophylaxis in ambulatory solid cancer patients undergoing chemotherapy

Saved in:

Bibliographic Details
Published in:	Thrombosis research Vol. 130; no. 5; pp. 821 - 822
Main Author:	Oo, Thein H
Format:	Journal Article
Language:	English
Published:	United States Elsevier Ltd 01-11-2012
Subjects:	Anticoagulants - therapeutic use Fibrinolytic Agents - therapeutic use Hematology, Oncology and Palliative Medicine Heparin - therapeutic use Humans Neoplasms - complications Neoplasms - drug therapy Venous Thromboembolism - etiology Venous Thromboembolism - prevention & control
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1 ObjectType-Commentary-2
ISSN:	0049-3848 1879-2472
DOI:	10.1016/j.thromres.2012.07.026